Clinical epidemiology, clinical care, and the public's health

Mayo Clinic Proceedings

Volumn 79, Issue 8, 2004, Pages 975-976

  Lauer, Michael S ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGING; CORONARY STENT; EDITORIAL; EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; HEALTH CARE QUALITY; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; OBSERVATION; PATIENT CARE; PUBLIC HEALTH SERVICE; REVASCULARIZATION;

EID: 3442899023     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.8.975     Document Type: Editorial

References (20)

1. Fletcher RH, Fletcher SW, Wagner EH. Clinical Epidemiology: The Essentials. 3rd ed. Baltimore, Md: Williams & Wilkins; 1996:2.
2. Vandenbroucke JP. When are observational studies as credible as randomised trials? Lancet. 2004;363:1728-1731.
3. Lauer MS. Medical therapy for coronary artery disease works, even (especially) in the real world [editorial]. Am J Med. 2001;110:497-498.
4. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med. 2000;342:1878-1886.
5. Humphrey LL, Chan BK, Sox HC. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med. 2002;137:273-284.
6. Perschbacher JM, Reeder GS, Jacobsen SJ, et al. Evidence-based therapies for myocardial infarction: secular trends and determinants of practice in the community. Mayo Clin Proc. 2004;79:983-991.
7. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360.
8. Keeley EC, Grines CL. Primary coronary intervention for acute myocardial infarction. JAMA. 2004;291:736-739.
9. Kober L, Torp-Pedersen C, Carlsen JE, et al, Trandolapril Cardiac Evaluation (TRACE) Study Group. A clinical trial of the angiotensin-converting- enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1995;333:1670-1676.
10. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. The Heart Outcomes Prevention Evaluation Study Investigators, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients [published corrections appear in N Engl J Med. 2000;342: 748 and 1376]. N Engl J Med. 2000;342:145-153.
11. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. The Heart Outcomes Prevention Evaluation Study Investigators, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients [published corrections appear in N Engl J Med. 2000;342: 748 and 1376]. N Engl J Med. 2000;342:145-153.
12. Rich MW. From clinical trials to clinical practice: bridging the GAP [editorial]. JAMA. 2002;287:1321-1323.
13. Chen J, Radford MJ, Wang Y, Marciniak TA, Krumholz HM. Do "America's Best Hospitals" perform better for acute myocardial infarction? N Engl J Med. 1999;340:286-292.
14. Bradley EH, Holmboe ES, Mattera JA, Roumanis SA, Radford MJ, Krumholz HM. A qualitative study of increasing beta-blocker use after myocardial infarction: why do some hospitals succeed? JAMA. 2001;285: 2604-2611.
15. Mehta RH, Montoye CK, Gallogly M, et al, GAP Steering Committee of the American College of Cardiology. Improving quality of care for acute myocardial infarction: the Guidelines Applied in Practice (GAP) Initiative. JAMA. 2002;287:1269-1276.
16. Ferguson TB Jr, Peterson ED, Coombs LP, et al. Society of Thoracic Surgeons and the National Cardiac Database. Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial. JAMA. 2003;290:49-56.
17. Topol EJ, Califf RM. Scorecard cardiovascular medicine: its impact and future directions. Ann Intern Med. 1994;120:65-70.
18. Omoigui NA, Miller DP, Brown KJ, et al. Outmigration for coronary bypass surgery in an era of public dissemination of clinical outcomes. Circulation. 1996;93:27-33.
19. Krumholz HM, Rathore SS, Chen J, Wang Y, Radford MJ. Evaluation of a consumer-oriented internet health care report card: the risk of quality ratings based on mortality data. JAMA. 2002;287:1277-1287.
20. Peterson ED, Coombs LP, DeLong ER, Haan CK, Ferguson TB. Procedural volume as a marker of quality for CABG surgery. JAMA. 2004;291: 195-201.